St. Louis, Missouri – January 22, 2008 – Partek Incorporated and Quimica Valaner have announced a distribution agreement under which Valaner will provide sales and marketing in Mexico for each of Partek’s software solutions. Partek’s software solutions include Partek^® Genomics Suite^TM, Partek^® Discovery Suite^TM, Partek^® QSAR Solution^TM, and Partek^® Screener’s Solution^TM, with each package integrating powerful statistical analysis with interactive data visualization, designed to target specific research areas in the life sciences market.

"Uniscience has a proven track record of meeting the needs of their customers with essential technology and software solutions. We look forward to this partnership, as we work together to provide powerful analysis software backed by outstanding customer support to the scientific communities throughout Brazil," said Tom Downey, President of Partek Inc.

Scientists at HRI will use Partek to analyze gene expression data generated from studies about the effects of sex hormones in heart disease and the link between diabetic kidney disease and heart disease. HRI is Australia’s leading institute for atherosclerosis research and was founded in 1989. HRI is located in New South Wales.

Researchers at MGH will use Partek to detect copy number variation in family research. MHG, the third oldest hospital in the United States, is dedicated to research that improves the lives of their patients. MHG is located in Boston.

Researchers at NIBR will use Partek GS to analyze genomic data. NIBR, Novartis’ research organization, is dedicated to finding new treatments for areas within dermatology, oncology, and immunology. Headquartered in Cambridge, Massachusetts, NIBR has sites all over the world including in Basel, Switzerland; Vienna, Austria; Horsham, UK; Tsukuba, Japan, Shanghai, China; and East Hanover, New Jersey.